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We previously reported that hepatitis C virus core protein (core) activates the transcription factor nuclear factor-kB (NF-kB)
when expressed transiently. In the present study, we investigated the relationship between the NF-kB activation capacity and
subcellular localization of the core. By changing the subcellular localization of the C-terminally truncated core from the
nucleus to the cytoplasm, NF-kB was activated. In addition, NF-kB activity was augmented by forcing the mutated core to
move to the endoplasmic reticulum. It was also suggested that the region from aa 21 to 80 of the core is involved in the
activation of NF-kB. © 2001 Academic Press
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lINTRODUCTION
Hepatitis C virus (HCV), which has been identified as
the major causative agent of non-A, non-B hepatitis
(Choo et al., 1989; Kuo et al., 1989), is classified as a
ember of the Flaviviridae family (Choo et al., 1991; Kato
et al., 1990; Takamizawa et al., 1991). HCV has a positive-
strand RNA genome consisting of an open reading frame
(ORF) composed of over 9000 nucleotides. This RNA
genome encodes a large precursor polyprotein, which is
cleaved by the host and viral proteases to generate at
least 10 functional viral proteins: core, envelope (E)-1, E2,
p7, nonstructural protein (NS)-2, NS3, NS4A, NS4B,
NS5A, and NS5B (Grakoui et al., 1993; Hijikata et al., 1991,
993; Lin et al., 1994; Mizushima et al., 1994b). Persistent
infection of HCV has been considered closely related to
chronic liver diseases such as chronic hepatitis, liver
cirrhosis, and hepatocellular carcinoma (Alter et al.,
1989; Choo et al., 1989; Kuo et al., 1989; Liang et al., 1993;
anaka et al., 1991). Although the pathogenesis of these
HCV-related diseases is still unknown, studies have sug-
gested a contribution by HCV proteins to the develop-
ment of these diseases.
Recently, it was reported that the core protein, which is
considered a viral structural protein processed from the
N-terminal region of the HCV precursor polyprotein (Gra-
koui et al., 1993; Hijikata et al., 1991), has the potential to
transform rat embryo fibroblasts, Rat-1 cells, NIH3T3
1 To whom reprint requests should be addressed at Department of
iral Oncology, Institute for Virus Research, Kyoto University, Sakyo-ku,t
yoto 606-8507, Japan. Fax: 81-75-751-3998. E-mail: mhijikat@
irus.kyoto-u.ac.jp.
391cells, and BALB/3T3 cells, although the coproduction of
oncogenic Ras protein was required for the transforma-
tion in some cases (Chang et al., 1998; Ray et al., 1996a;
suchihara et al., 1999). It was also reported that trans-
enic mice expressing the core developed hepatocellu-
ar carcinoma after the age of 16 months (Moriya et al.,
998). These observations prompted the idea that the
ore has oncogenic potential and is closely related to
epatocarcinogenesis, when this viral protein is consti-
utively expressed in liver cells. In general, however,
ells which are infected with a virus and producing viral
roteins are believed to be attacked by the host immune
ystem. Recent studies have suggested that apoptosis
nduced by cytotoxic T lymphocytes plays an important
ole in the clearance of infected cells (Moretta, 1997;
’Brien, 1998). As chronic infection is a characteristic
eature of HCV, the possibility exists that HCV-infected
ells become resistant to apoptosis induced by the host
mmune system. Several studies on the relationship be-
ween apoptosis and HCV proteins have been reported
Fujita et al., 1996; Marusawa et al., 1999; Ray et al.,
996b, 1998; Ruggieri et al., 1997; Zhu et al., 1998). Re-
ently, we found that cultured cells transiently express-
ng the entire ORF of the HCV genome became resistant
o Fas- and tumor necrosis factor a-mediated apoptosis
nd that the core among HCV proteins was responsible
or this effect (Marusawa et al., 1999). We further sug-
ested that the anti-apoptotic effect of the core was
elated to the activation of the transcription factor nu-
lear factor kB (NF-kB) by this viral protein in some cell
ines.
We and others reported that the core showed potential
o activate NF-kB in HepG2, MCF-7, Jurkat, and HeLa
0042-6822/01 $35.00
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392 WATASHI ET AL.cells transiently producing this protein (Kato et al., 2000;
Marusawa et al., 1999; Tai et al., 2000). On the other
and, it was also reported that NF-kB activity in the cell
lines which were established as permanent transfec-
tants of the core was variable (Shrivastava et al., 1998;
You et al., 1999; Zhu et al., 1998). Although the effect of
long-term production of the core on NF-kB activity re-
mains to be clarified, the transiently produced core pro-
tein is likely to have the potential to activate NF-kB.
NF-kB is known to be involved in a variety of physiolog-
ical events, for example, cell proliferation, differentiation,
survival, and inflammatory response (Gerondakis et al.,
1999; May and Ghosh, 1998). Therefore, activation of
NF-kB by the core seems to contribute to the pathogen-
esis of HCV.
Previously, we have reported that the core with a
truncated C-terminal region lost its ability to activate
NF-kB (Marusawa et al., 1999). We also found that the
subcellular localization of this truncated core was mainly
confined to the nucleus, while the wild-type core which
was primarily translated as a polypeptide of 191 amino
acids was located in the cytoplasmic perinuclear region
(Marusawa et al., 1999). However, it was unclear whether
the NF-kB activation potential was lost through alteration
f the subcellular localization or deletion of the active
ite. As it was reported that a certain molecule of the
ild-type core is located in the nucleus (Yasui et al.,
998), it has been unknown whether the core activates
F-kB in the perinuclear region of the cells. Therefore, in
this study, we tried to analyze the molecular mechanism
of NF-kB activation by the HCV core. Here, we report a
correlation between the subcellular localization and
NF-kB activation capacity of the core and the region of
the core essential for the activity.
RESULTS
Cytoplasmic localization of the core is important for
its NF-kB activation capacity
Our previous results indicated that the core activates
transcription factor NF-kB when this protein is transiently
xpressed in several human cell lines, including HepG2
nd MCF-7 cells (Marusawa et al., 1999). To examine
hether NF-kB is also activated in murine-derived cells,
the expression plasmids, pCMV-Core, pCMV-DCore173,
pCMV-DCore151, and pCMV-DCore100, encoding 1–191
aa (C191), 1–173 aa (C173), 1–151 aa (C151), and 1–100
aa (C100) of the core, respectively, were transfected into
NIH3T3 cells. Subsequently, NF-kB activity in the trans-
fected cells was evaluated by dual-luciferase reporter
assay. As shown in Fig. 2A, we found a seven- to eight-
fold augmentation of relative luciferase activity in the
cells producing either C191 and C173, compared to that
in the cells transfected with an empty vector, pKS1/CMV,
as a negative control (Fig. 1A, lanes 1–3). The observed
activation of reporter gene expression was likely to be
i
pNF-kB-specific because the transcription from the re-
porter plasmid whose promoter contained the mutated
element of the NF-kB binding sequence was not affected
by any core products (data not shown). In contrast, the
relative luciferase activity of the cells transfected with
pCMV-DCore151 and pCMV-DCore100, which encoded
the core with larger deletions in the C-terminal region,
was not augmented (Fig. 1A, lanes 1, 4, and 5). As the
production levels of these core derivatives were con-
firmed to be almost equal by immunoblotting analysis
(Fig. 1B, lanes 2–4), it was likely that the C-terminal
region of the core is required for NF-kB activation. These
results were consistent with those of our previous ex-
periments using HepG2 and MCF-7 cells (Marusawa et
al., 1999). This suggested that the core activates NF-kB
in cells irrespective of the mammalian species. Then, to
see whether the C-terminal region of the core itself has
the NF-kB activation capacity, we examined whether the
ransfection of pCMV-DCore(101–191) for expression of
he C-terminal part of the core caused NF-kB activation
n NIH3T3 cells. As shown in Fig. 1A, we did not observe
ny enhancement of the relative luciferase activity in the
ells transiently producing this protein (Fig. 1A, lane 6).
his indicated that only the C-terminal region of the core
s incapable of activating NF-kB.
Next, we analyzed the subcellular localization of each
C-terminally deleted core protein by indirect immunoflu-
orescence microscopy. As shown in Fig. 1C, when C191
was produced, this protein was found to be located
around the perinuclear region in the cytoplasm (Fig.
1Ca). And C173 was detected in both the nucleus and the
cytoplasm (Fig. 1Cc). However, the subcellular localiza-
tion of C151 and C100 was quite different from that of
C191 and C173. These deletion mutant core proteins
were mainly detected in the nucleus (Figs. 1Ce and 1Cg).
The results were similar to those of our previous study
and others in which experiments were carried out using
human cell lines (Barba et al., 1997; Marusawa et al.,
999). Given the above results, it is highly likely that
ytoplasmic localization of the core is important for ac-
ivation of NF-kB. Therefore, we examined whether
NF-kB activity is enhanced when the subcellular local-
ization of C151, which did not activate NF-kB, is changed
rom the nucleus to the cytoplasm by addition of several
odifications to this protein as follows: (1) fusion with a
eptide containing the nuclear export signal (NES), (2)
usion with an uncleavable peptide with a signal se-
uence at the C-terminal end, (3) introduction of a point
utation into the nuclear localization signal (NLS) of the
ore.
For the construction of the NES fusion protein, we
sed the NES of the human T-cell leukemia virus type-I
HTLV-1) Rex protein and fused it at the C-terminus of
151 (Bogerd et al., 1995). Since NES is known to benvolved in active transport from the nucleus to the cyto-
lasm (Turpin et al., 1999; Wen et al., 1995), it was
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393NF-kB ACTIVATION MECHANISM BY HCV COREFIG. 1. Effect of altered cytoplasmic localization of the C-terminally truncated core on NF-kB activation capacity. (A) NF-kB activation capacity of
he core mutants. NIH3T3 cells (1 3 104) were transfected with 0.05 mg of pRL-TK, 0.05 mg of pNF-kB-Luc, and 0.5 mg of various expression plasmids
(pKS1/CMV in lane 1, pCMV-Core in lane 2, pCMV-DCore173 in lane 3, pCMV-DCore151 in lane 4, pCMV-DCore100 in lane 5, pCMV-DCore(101–191)
in lane 6, pCMV-NES in lane 7, pCMV-DCore151-NES in lane 8, pCMV-p7 in lane 9, pCMV-DCore151-p7 in lane 10, and pCMV-DCore151 (NLS mut)
in lane 11) with 1.2 ml of FuGENE 6. After 40 h, a whole cell lysate was prepared and assayed for firefly and Renilla luciferase activity. Luciferase
ctivities for the index of NF-kB activity were calculated with firefly luciferase activity divided by Renilla luciferase activity. The data represent the mean
f this relative luciferase activities from three independent experiments. The values of standard deviation are shown. (B) Expression levels of the core
utants produced in NIH3T3 cells. NIH3T3 cells (3 3 104) were transfected with 2.0 mg of each expression plasmid by using 3.0 ml of FuGENE 6.
t 40 h posttransfection, the level of production of the core mutants was analyzed by SDS–polyacrylamide gel electrophoresis followed by
mmunoblotting analysis. The upper left and right panels show the proteins detected by anti-core (515S) and anti-FLAG, respectively. Molecular mass
arkers (in kilodaltons) are shown on the left. The lower panels indicate the production level detected by using anti-a-tubulin as an internal control.
Plasmids which were transfected into the cells were as follows: Lane 1 and 9, pKS1/CMV; lane 2, pCMV-Core; lane 3, pCMV-DCore173; lane 4,
pCMV-DCore151; lane 5, pCMV-DCore151-NES; lane 6, pCMV-DCore151-p7; lane 7, pCMV-DCore151(NLS-mut); lanes 8 and 12, pCMV-FLAG-Core; lane
10, pCMV-DHFR-FLAG-NES; lane 11, pCMV-DHFR-FLAG-p7. (C) Subcellular localization of the core mutants. NIH3T3 cells transfected with each
expression plasmid pCMV-Core in a and b, pCMV-DCore173 in c and d, pCMV-DCore151 in e and f, pCMV-DCore100 in g and h, pCMV-DCore151-NES
in i and j, pCMV-DCore151-p7 in k and l, and pCMV-DCore151 (NLS-mut) in m and n are shown. At 40 h posttransfection, the cells were fixed,
permeabilized with 0.05% Triton X-100, and stained with anti-core antibody, and the immunocomplexes were detected with Alexa 568 goat anti-mouse
IgG (H 1 L) conjugates (a, c, e, g, i, k, and m). Staining of the nucleus by DAPI in the same cells is shown in b, d, f, h, j, l, and n.
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394 WATASHI ET AL.expected that a nuclear protein is exported to the cyto-
plasm by fusion with the NES sequence. The second
modification was introduced by HCV p7 protein used as
the C-terminal fusion partner. HCV p7 is considered to
function as a signal sequence for NS2 protein during the
proteolytic processing of HCV precursor polyprotein (Lin
et al., 1994; Mizushima et al., 1994a,b). As secondary
cleavage in p7 polypeptide was not observed (Lin et al.,
1994; Mizushima et al., 1994b), the fused p7 was ex-
pected to function as an anchor for localization of the
fusion protein on the surface of ER, similar to the wild-
type core protein. For the third modification, we intro-
duced a single amino acid mutation in the putative NLS
of the core in order to render it inactive. Loss of NLS
function was expected to result in the alteration of local-
ization of the truncated core C151 to the cytoplasm. A
previous report suggested that the region aa 38–43 of the
core is the most active among the three or four putative
NLSs (Chang et al., 1994; Suzuki et al., 1995). Conse-
quently, to inactivate NLS, we substituted arginine for
threonine at position 40 of the C151 protein (C151 (NLS
mut)).
After the confirmation of protein production by immu-
noblotting analysis (Fig. 1B, lanes 5–7), we observed the
subcellular localization of each construct by indirect im-
munofluorescence analysis. NES-fused C151 (C151-NES)
and C151 (NLS mut) were distributed in both the nucleus
and the cytoplasm in contrast to the nuclear localization
of C151 (Fig. 1Ce, 1Ci, and 1Cm). In the case of C151-p7,
alteration of the location was more obvious. As shown in
Fig. 1Ck, the nuclear localization of C151 was changed to
the perinuclear region in the cytoplasm by fusion with the
signal sequence. Next, we examined NF-kB activity in
he cells producing these proteins. As negative controls,
F-kB activity was evaluated in the cells transfected with
the plasmid producing FLAG-tagged NES and FLAG-
tagged p7 without the core polypeptide and with pCMV-
DHFR-FLAG-NES and pCMV-DHFR-FLAG-p7 producing
FLAG-tagged NES and FLAG-tagged p7 fused with
mouse dihydrofolate reductase (DHFR), respectively.
DHFR is a cytoplasmic cellular protein similar in molec-
ular size to the core. Although the level of reporter activity
in the cells producing negative control constructs was
quite similar to that in the cells producing C151, the cells
producing C151-NES, C151-p7, and C151 (NLS mut)
showed 4.1-, 9.6-, and 3.3-fold, respectively, higher lucif-
erase activities than the cells producing C151 (Fig. 1A,
lanes 4 and 7–11). These data indicated that C151 has
the potential to activate NF-kB when it is located in the
cytoplasm. Similar results were obtained using HepG2
cells (data not shown). From the above results, the fol-
lowing conclusions have been reached: (1) cytoplasmic
localization of the core is important for its NF-kB activa-
ion capacity, (2) the N-terminal region of 151 aa rather
han the C-terminus of 40 aa of the core is required for
e
mhe NF-kB activation, (3) the C-terminal region of the core
functions to retain this protein in the cytoplasm.
The core is exposed on the cytosolic side of the
endoplasmic reticulum membranes
As shown in Fig. 1A, the NF-kB activity of the cells
producing C151-NES and C151 (NLS mut) was relatively
weaker than that producing C191, whereas C151-p7
showed the same activation capacity as C191. As the
production level of each protein was almost the same,
the difference found in the effect of C151-p7 from those of
C151-NES or C151 (NLS mut) seemed to be due to the
different subcellular localization of this product. While
C151-NES and C151 (NLS mut) were detected in both the
nucleus and the cytoplasm, we observed that C151-p7 is
located mainly around the perinuclear region, the same
as C191 (Fig. 1Ci, 1Ck, and 1Cm). Therefore, we presume
that NF-kB activation by the core is closely related to its
localization around the perinuclear region. Since both
C191 and C151-p7 have signal sequences in their C-
termini, these proteins are likely to be located on endo-
plasmic reticulum (ER) membranes. Moreover, the core
was suggested to be located on the outside of microso-
mal membranes by in vitro processing analysis for HCV
structural proteins (Hijikata et al., 1991). In order to in-
estigate this point precisely, we analyzed the subcellu-
ar localization of C191 and C151-p7 by an indirect im-
unofluorescence technique. In this experiment, we
sed Grp78, which is also termed Bip and known to be
ocated mainly in the lumen of ER (Haas, 1994), as a
arker for ER. At first, NIH3T3 cells transfected with
CMV-Core or pCMV-DCore151-p7 were permeabilized
ith Triton X-100 for detection of the exogenous core
erivatives and endogenous Grp78 by anti-core antibody
nd anti-Grp78 antibody, respectively. As shown in Fig. 2,
mmunofluorescence patterns for C191 and C151-p7
ere similar to that for Grp78 (Figs. 2a, 2c, 2g, and 2i),
uggesting that these proteins are located around the
R. Next, to investigate on which side of the ER mem-
ranes, the lumen or cytoplasmic side, C191 and
151-p7 are located, we performed a modified indirect
mmunofluorescence analysis in which digitonin was
sed for permeabilization of the cells instead of Triton
-100. Digitonin is a reagent that permeabilizes the
lasma membranes effectively but not the intracellular
embranes (Liu et al., 1999; Pollenz et al., 1992). Under
hese conditions, C191 and C151-p7 were detected
round the perinuclear region (Figs. 2c, 2f, 2i, and 2l), just
s in the cells treated with Triton X-100. However, we did
ot detect Grp78 in digitonin-permeabilized cells, the ER
embranes of which should be largely intact to protect
his protein from the antibody (Figs. 2a, 2d, 2g, and 2j).
hese results suggested that C191 and C151-p7 are
xposed to the cytoplasm on the surface of the ER
embranes.
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395NF-kB ACTIVATION MECHANISM BY HCV CORENF-kB activation by the core is closely related with
ER localization of this viral protein
The above results suggested that localization of the
core to ER membranes is important for NF-kB activation.
To examine this possibility, we developed an experimen-
tal system in which subcellular localization of the core
derivative can be conditionally changed from the cyto-
plasm to the surface of rough ER membranes. In this
system, we used the expression plasmid for a fusion
protein composed of the C-terminally deleted core which
has a mutation in its NLS, HA epitope tag, and the
N-terminal 212 aa of HCV NS3 (DCore-NS3.1) (Fig. 3). As
the core part of this fusion construct, we used the region
from aa 1 to 100 of the core. This region of the core
entirely lost the C-terminal hydrophobic structures of this
protein to reduce the affinity of this protein to the mem-
branes. This region was confirmed to activate NF-kB
hen it was fused with FLAG-tagged p7. The N-terminal
egion of NS3 in DCore-NS3.1 was suggested to function
or anchorage on the rough ER membrane through the
nteraction with HCV NS4A which was already reported
o be localized on the membranes (Failla et al., 1995;
FIG. 2. Detection of Grp78 and the core after permeabilization with Tr
pCMV-Core in a to f and pCMV-DCore151-p7 in g to l are shown. At 40
(a, b, c, g, h, and i) or 40 mg/ml digitonin (d, e, f, j, k, and l), and stained
ere detected with Alexa 568 goat anti-rabbit IgG (H 1 L) conjugates
nd l). Staining of the nucleus by DAPI in the same cells is shown inijikata et al., 1993; Satoh et al., 1995; Tanji et al., 1995).
Therefore, in the presence of NS4A, DCore-NS3.1 was
(
cexpected to be located on the ER membranes through
the association with this membrane protein. As a nega-
tive control, we prepared the fusion protein, DCore-
NS3.2, which was identical to the DCore-NS3.1 except for
the deletion of the NS4A binding region of DCore-NS3.1
corresponding to the N-terminal 22 aa of NS3 (Failla et
al., 1995; Satoh et al., 1995) (Fig. 3). At first, we observed
ubcellular localization of these proteins in the presence
r absence of NS4A (Fig. 4A). Both DCore-NS3.1 and
Core-NS3.2 were found to be distributed in the nucleus
nd cytoplasm in the absence of NS4A (Figs. 4Aa and
Af), as observed in the case of C151 (NLS mut) (Fig.
Cm). However, when DCore-NS3.1 was coproduced
ith NS4A, this fusion protein was found to accumulate
round the perinuclear region and colocalize with NS4A
n the cells (Figs. 4Ac and 4Ae). On the other hand,
Core-NS3.2 lacking the NS4A binding region was dis-
ributed in both the nucleus and the cytoplasm even in
he presence of NS4A (Fig. 4Ah). When NS4A was pro-
uced in the cells, subcellular localization of NS4A was
lways observed to be around the perinuclear cytoplas-
ic region as reported previously (data not shown)
00 or digitonin. NIH3T3 cells transfected with each expression plasmid
ansfection, the cells were fixed, permeabilized with 0.05% Triton X-100
nti-core antibody and anti-Grp78 antibody, and the immunocomplexes
, and j) and Alexa 488 goat anti-mouse IgG (H 1 L) conjugates (c, f, i,
and k.iton X-1
h posttr
with aSelby et al., 1993; Tanji et al., 1995). These results indi-
ated that DCore-NS3.1 was trapped around the rough
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396 WATASHI ET AL.ER membranes through the interaction with mem-
brane-located NS4A. Under these conditions, we in-
vestigated the NF-kB activity in each cell. Compared
with the negative control, no significant augmentation
of NF-kB activation was found in the cells transfected
ith pCMV-DCore-NS3.1, pCMV-DCore-NS3.2, or pSPC-
S4A, indicating that these proteins do not have marked
F-kB activation capacities by themselves (Fig. 4B, lanes
2, 4, and 6). The NF-kB activity in the cells producing
Core-NS3.2 with NS4A was also the same as that in
egative control cells (Fig. 4B, lanes 1 and 5). In contrast,
bout a 2.9-fold augmentation of NF-kB activity was
found in the cells producing both DCore-NS3.1 and
NS4A, compared with the cells producing DCore-NS3.1
without NS4A (Fig. 4B, lanes 2 and 3). We observed that
the production level of each exogenous protein was
almost identical in each transfectant (Fig. 4C). We also
confirmed that both DCore-NS3.1 and DCore-NS3.2 pro-
eins have the capacity to activate NF-kB when produced
as forms fused with p7 to be located around the perinu-
clear cytoplasmic region (data not shown). From the
above results, it was suggested that activation of NF-kB
FIG. 3. Schematic representations of the HCV core protein deriva-
ives encoded in the expression plasmid. The primarily processed form
f the core is shown at the top. The core regions in deletion constructs
re shown by bars. The numbers above the bars indicate the amino
cid number of the viral precursor polyprotein. The shaded, hatched,
pen, checked, and closed boxes indicate the NES of HTLV-1 Rex, HCV
7, FLAG tag, HA tag, and HCV NS3, respectively.y the core is closely related to its localization to the
ough ER membranes.he region from aa 21 to 80 of the core is essential
or efficient NF-kB activation
To identify the structure of the core which is involved in
F-kB activation, we examined the activation capacity of
a variety of truncated cores fused with FLAG-tagged p7.
As shown in Fig. 5, significant augmentation of NF-kB
activity was found in the cells transfected with pCMV-
DCore100-p7, pCMV-DCore80-p7, and pCMV-DCore60-
p7, compared to the negative controls, FLAG-p7 and
DHFR-FLAG-p7, whereas pCMV-DCore40-p7 and pCMV-
DCore20-p7 showed reduced NF-kB activation potentials
Fig. 5, lanes 3–8 and 12). The reduced potentials
eemed to be marginal, because DCore40-p7 and
Core20-p7 did not activate NF-kB in HepG2 cells at all,
espite reproduced observations of the augmentation of
F-kB activity by DCore100-p7, DCore80-p7, and
DCore60-p7 in the cells (data not shown). To narrow
down the core region required for the NF-kB activation,
another deletion mutant was examined. We found inter-
mediate activation of NF-kB in the cells producing aa
1–60 of the core (Fig. 5, lane 10). We confirmed that the
roduction levels and perinuclear localizations of these
himeric proteins were similar to each other in NIH3T3
nd HepG2 cells by immunoblotting and indirect immu-
ofluorescence analyses (data not shown). These data
uggested that the region from aa 21 to 60 of the core is
ssential for the efficient activation of NF-kB. In addition,
hen the region from aa 61 to 80 was lost, NF-kB activity
was reduced (Fig. 5, lanes 5, 6, 9, and 10). Therefore, it
was supposed that the region aa 61–80 of the core plays
a supportive role in NF-kB activation. To test the above
conclusion, we examined the potential of the p7-fused
C151 lacking aa 21–80 of the core and found no NF-kB
ctivation in the cells producing that deletion construct
Fig. 5, lane 11).
DISCUSSION
In this study, we showed that the cytoplasmic local-
zation of the core is essential for the activation of NF-kB
by this viral protein. We also obtained data suggesting
that the core is localized to the ER membranes exposing
some parts to the cytoplasm. Moreover, we revealed that
the localization of the core to the membranes of rough
ER is important for the activation of NF-kB. This sug-
ested that activation by the core occurred in the cyto-
lasm rather than in the nucleus, although nuclear local-
zation of the core was reported (Yasui et al., 1998). It is
ell-established that one of the major regulatory mech-
nisms for NF-kB activity is present in the cytoplasm as
ollows. Under dormant conditions, NF-kB activity is neg-
tively regulated by the formation of a complex with IkB
n the cytoplasm. NF-kB activation signals induce phos-
horylation and subsequent degradation of IkB throughthe kination cascade including IkB kinase (IKK) a, b, and
g, resulting in dissociation of NF-kB from IkB. Subse-
t
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397NF-kB ACTIVATION MECHANISM BY HCV COREFIG. 4. Effect of conditional localization of the mutated core around the ER membrane on NF-kB activation capacity. (A) Subcellular localization of
he core-NS3 chimera in the presence of NS4A. A total of 1.0 mg of pCMV-DCore-NS3.1 and 0.25 mg of pKS1/CMV (a and b), 1.0 mg of
CMV-DCore-NS3.1 and 0.25 mg of pSPC-NS4A (c, d, and e), 1.0 mg of pCMV-DCore-NS3.2 and 0.25 mg of pKS1/CMV (f and g), and 1.0 mg of
pCMV-DCore-NS3.2 and 0.25 mg of pSPC-NS4A (h, i, and j), respectively, were transfected into NIH3T3 cells. The immunocomplexes reactive with
anti-core and anti-NS4A antibody were detected with Alexa 568 (left) and Alexa 488 (right) goat anti-mouse IgG (H 1 L) conjugates, respectively. DAPI
was also used for the nuclear staining (center). (B) NF-kB activation capacity when the core-NS3 chimera was produced with or without NS4A. A total
of 0.4 mg of pCMV-DCore-NS3.1 or pCMV-DCore-NS3.2 was transfected into NIH3T3 cells with 0.1 mg of pSPC-NS4A or pKS1/CMV. The luciferase
ctivities were measured as described in the legend to Fig. 1A. The results of the cells transfected with pKS1/CMV, pCMV-DCore-NS3.1,
CMV-DCore-NS3.1 and pSPC-NS4A, pCMV-DCore-NS3.2, pCMV-DCore-NS3.2 and pSPC-NS4A, and pSPC-NS4A were shown in lanes 1, 2, 3, 4, 5,
nd 6, respectively. (C) Production levels of the core-NS3 chimera and NS4A in NIH3T3 cells. NIH3T3 cells were transfected as indicated for (B).
mmunoblotting analyses were performed as described for Fig. 1B for the detection of the expression levels of the core mutants (top), NS4A (middle),
nd a-tubulin (bottom) were used as the internal controls. Molecular mass markers (in kilodaltons) are shown on the left. The arrow indicates NS4A
protein. The open circle represents a possible degradation product of NS4A.
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398 WATASHI ET AL.quently, the released NF-kB enters the nucleus and in-
duces the expression of numerous genes (Karin, 1999;
Pahl, 1999). Therefore, our results are likely to indicate
that the core modulates a certain step of this cytoplasmic
NF-kB signaling pathway.
Recently, it has been reported that some viral proteins
such as adenovirus E3/19K protein and influenza virus
hemagglutinin protein caused NF-kB activation by over-
accumulation in the ER lumen (Pahl and Bauerle, 1995,
1997; Pahl et al., 1996). This NF-kB activation, so-called
ER overload, is considered to be triggered by the release
of calcium cations from the ER and followed by produc-
tion of reactive oxygen species (Pahl et al., 1997). How-
ever, this typical ER overload did not seem to be involved
in NF-kB activation by the core for the following reasons.
irst, NF-kB activation by ER overload is caused by
sensing an overaccumulation of proteins in the ER lu-
men. However, the region of aa 21–80 of the core
seemed to be present on the cytoplasmic side of the ER,
not in the lumen, because the epitope of the anti-core
antibody used in this study was located among aa 21–40
of the core, which was included in the above functional
region of the core. Second, although it was reported that
the ER stress causes not only the activation of NF-kB but
also the reduction of translational activity in the cells, we
found no remarkable reduction in translation and moni-
tored the increased production level of the luciferase
induced by the core production. Third, the core mutant,
FIG. 5. The identification of the region of the core involved in NF-kB
activation. NIH3T3 cells were transfected with 0.5 mg of each expres-
sion plasmid, pKS1/CMV (lane 1), pCMV-Core (lane 2), pCMV-FLAG-p7
(lane 3), pCMV-DCore100-FLAG-p7 (lane 4), pCMV-DCore80-FLAG-p7
(lane 5), pCMV-DCore60-FLAG-p7 (lane 6), pCMV-DCore40-FLAG-p7
(lane 7), pCMV-DCore20-FLAG-p7 (lane 8), pCMV-DCore(21–80)-
FLAG-p7 (lane 9), pCMV-DCore(21–60)-FLAG-p7 (lane 10), pCMV-
DCore(1–20 1 81–151)-FLAG-p7 (lane 11), and pCMV-DHFR-FLAG-p7
(lane 12). The luciferase activities were measured as indicated for Fig.
1A.which did not show any affinity to the membranes, acti-
vated NF-kB when it was localized around the ER mem-branes through interaction with NS4A, which does not
activate NF-kB.
Until now, there has been no report suggesting that
ny of the NF-kB activation factors such as the IKK
complex are located around the ER membrane. It seems
possible, however, that the localization of the core to the
ER membranes creates an opportunity for interaction
with a cellular factor leading to NF-kB activation. Re-
cently, it was suggested from the results obtained by a
yeast two-hybrid system that the core interacted with the
intracellular domain of lymphotoxin-b receptor (LT-bR)
nd tumor necrosis factor receptor 1 (TNFR 1) (Chen et
l., 1997; Matsumoto et al., 1997; Zhu et al., 1998). Gen-
rally, integral membrane proteins such as ligand recep-
ors of plasma membranes are translated by the ribo-
omes on the rough ER and their extracellular portions
re translocated into the lumen of ER cotranslationally.
hese primary translation products are subsequently gly-
osylated at the portion in the lumen and transported to
he plasma membrane through the Golgi apparatus and
ndosomal network. This means that the core may have
n opportunity to interact with the cytoplasmic region of
hese newly synthesized plasma membrane proteins.
his type of molecular interaction on the intracellular
embrane has been recently reported. A cellular factor
nown as the silencer of death domain (SODD) was
ound to interact with the cytoplasmic domain of TNFR 1
nd locate around the Golgi apparatus (Jiang et al., 1999).
t was suggested that SODD bound to TNFR 1 is trans-
ocated to the plasma membrane and suppresses the
ignal from TNFR 1 introduced by TNF, although the
ajority of SODD was found to be located around the
olgi apparatus. The core was also reported to associ-
te with TNFR 1 (Zhu et al., 1998), although the core has
o significant amino acid sequence homology to the
ODD. Matsumoto et al. showed that the region from aa
6 to 91 of the core binds to LT-bR (Matsumoto et al.,
997). Chen et al. also reported that the N-terminal 40-aa
egion of the core is important for the interaction with
T-bR by in vitro binding analysis using a recombinant
truncated core protein fused to GST (Chen et al., 1997).
The former LT-bR interaction region of the core almost
overlapped with aa 21–80 of the core which was ob-
served to be involved in the NF-kB activation in this
aper. Therefore, it is possible that the core activates
F-kB through the interaction with these receptor mole-
cules. Although there have been no reports indicating
that the core is located on the inner surface of the
plasma membranes, a part of the core bound with those
receptor molecules may be transported to the plasma
membranes and enhance the signal of NF-kB activation,
in contrast to SODD. Then, how is the core supposed to
function for NF-kB activation when it binds to TNFR 1?
One possibility is that the core may function like TRADD
and enhance NF-kB activity. TRADD is known as an
adaptor molecule for TNFR 1 and TRAF 2 and has been
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399NF-kB ACTIVATION MECHANISM BY HCV COREsuggested to mediate signal transduction for NF-kB ac-
tivation by TNFa stimulation (Karin, 1999). Another pos-
sibility may be that the core competes for binding to
TNFR 1 with SODD which suppresses NF-kB activation.
urther studies are necessary to determine whether the
nteraction between the core and TNFR 1 or LT-bR is
correlated with the activation of NF-kB by the core and
whether there is other candidate(s) that associates with
the core for the activation after the ER membrane local-
ization of the core.
To see whether the activation region of the core
shares characteristic features with other proteins which
have been reported to be involved in activation of NF-kB,
a homology analysis of the amino acid sequence was
performed. The results showed that the region of the Tax
protein corresponding to aa 61–74 of HTLV-1 (GRVIG-
SALQFLIPR) has 71% similarity with the core in the re-
gion of aa 28–39 (GQIVGGVYLLPR). Tax has been re-
ported to be associated with plural targets, NF-kB sub-
nits, IkB, IKKg, MEK kinase 1, and NF-kB inducing
inase (NIK) among the molecules composing the NF-kB
ignaling pathway (Sun and Ballard, 1999). This may
mply that the core shares some targets for the NF-kB
activation with Tax, although the subcellular localization
of Tax seems to be different from that of the core. How-
ever, our preliminary data showed no interaction be-
tween the core and NIK or IkBa in vitro (data not shown).
Further analyses to see whether this region of the core is
associated with cellular factors including these mole-
cules are now underway.
We previously suggested that NF-kB activation is part
f the anti-apoptotic effect of the core (Marusawa et al.,
999). Moreover, as NF-kB is suggested to play an im-
portant role in the transformation of cells or known to
regulate a variety of inflammatory cytokines (Pahl, 1999;
Yamaoka et al., 1996), NF-kB activation by the core is
likely to be involved in the hepatocarcinogenesis or the
development of HCV diseases. In order to determine the
cause of these diseases, further analysis on the mech-
anism of NF-kB activation by the core is required.
MATERIALS AND METHODS
Plasmid constructs
The expression plasmids used in this study are sum-
marized and schematically represented in Fig. 3. These
plasmids were constructed by insertion of the DNA frag-
ments amplified by polymerase chain reaction (PCR)
using Pfu polymerase (Promega) or synthesized oligonu-
cleotides into the pKS1/CMV vector (Hijikata et al.,
1993). pCMV-Core, pCMV-DCore173, and pCMV-
DCore151 were constructed as described previously
(Marusawa et al., 1999). pCMV-DCore100 was con-
structed with the fragment amplified by PCR using oligo-
nucleotides core-s (Marusawa et al., 1999) and 59-ACA-
GAATTCTAGGGTGACAGGAGCCATC-39 as primers andpCMV-Core as the template. pCMV-DCore (101–191)
was generated by inserting the PCR product obtained
using the oligonucleotides 59-GTTGGATCCATGCGTG-
GCTCCCGGCCTAATTG-39 and 59-CTCGAATTCTCAAG-
CGGAAGCTGGGATGGTCA-39 as primers into pKS1/
CMV in the same manner. pCMV-DCore151-NES and
pCMV-DCore151-p7 were produced by ligating PCR
products A and B, respectively, into EcoRI–HindIII-
digested pCMV-DCore151. PCR product A was pre-
pared by using pRSV-Tax (Hirowatari et al., 1995) as
the template and the oligonucleotides 59-ACAGAAT-
TCGCGTTATCGGCTCA-39 and 59-TTCAAGCTTTCAG-
AGTCGAGGGATA-39 as primers. PCR product B was
obtained by using pCMV-3010 (Marusawa et al., 1999)
s the template and the oligonucleotides 59-ACAGAAT-
CGGCCTTCTCTCCTTCCTCGTGTT-39 and 59-TTCAA-
CTTTCAGGCATAAGCTCGTGGTGGTAA-39 as primers
the latter oligonucleotide was named p7-AS). pCMV-
Core151 (NLS mut) was produced by oligonucleotide-
irected mutagenesis using 59-TTGCCGCGCACGGGC-
CCAGGT-39 and 59-ACCTGGGGCCCGTGCGCGGCAA-39
s primers (Mizushima et al., 1994a). The fragment ampli-
ied by PCR with oligonucleotide 59-ACAGAATTCCACA-
ATCTGGCCTTCTCTCCTTCCTCGTGTT-39 and p7-AS as
primers and pCMV-3010 as a template was ligated into
the EcoRI–HindIII sites of the pKS1/CMV vector and
the resultant plasmid was named pCMV-p7. Subse-
quently, pCMV-FLAG-p7 was generated by ligating the
fragment prepared by annealing oligonucleotides 59-
AATTCATGGATTACAAGGATGACGACGATAAGA-39 and 59-
GATCTCTTATCGTCGTCATCCTTGTAATCCATG-39 into the
EcoRI–BglII sites of pCMV-p7. pCMV-DCore100-FLAG-p7,
pCMV-DCore80-FLAG-p7, pCMV-DCore60-FLAG-p7, pCMV-
Core40-FLAG-p7, pCMV-DCore20-FLAG-p7, pCMV-
DCore(21–80)-FLAG-p7, pCMV-DCore(21–60)-FLAG-p7, and
CMV-DCore(1–20 1 81–151)-FLAG-p7 were prepared by
eplacing the BamHI–EcoRI fragment of pCMV-FLAG-p7
ith the BamHI–EcoRI digests of PCR products C, D, E,
, G, H, I, and J, respectively. The PCR products C, D,
, F, G, H, and I were amplified by using pCMV-Core as
template and oligonucleotides core-s and 59-
CAGAATTCGGGTGACAGGAGCCATC-39 , 59-ATA-
AATTCCCCGGGCTGAGCCCAGGTCC-39 (core80-AS),
9-TGTGATTCTCCACGAGGTTGCGA-39 (core60-AS),
9-TGTGAATTCCCTGCGCGGCAACAGGTAAA-39, and
9-TGTGAATTCCTGTGGGCGGCGGTTGGTGTTA-39, for
C, D, E, F, and G, respectively, oligonucleotides 59-
TCTGGATCCATGGACGTTAAGTTCCC-39 (Core21-S)
and core80-AS for H, and core21-S and core60-AS for
I as primers. The PCR product J was obtained through
a two-step PCR reaction. The first PCR products were
obtained using core-s and oligonucleotides 59-
GAGGGGCCAAGGGTACTGTGGGCGGCGGTT-39 for
the PCR product named J1 and 59-ACTGAATTC-
CAGGGCCCTGGCAACGCCTC-39 (named core151-AS)
and 59-AACCGCCGCCCACAGTACCCTTGGCCCCTC-39
400 WATASHI ET AL.for the PCR product J2 as primers and pCMV-Core as
a template. The second PCR was performed with J1
and J2 as templates and core-s and core151-AS as
primers to obtain the J PCR product. pCMV-DCore-
NS3.1 and pCMV-DCore-NS3.2 were produced by in-
serting three fragments generated as follows into
pCMV-FLAG-p7. Initially, the fragment synthesized by
annealing oligonucleotides 59-AATTCTACCCATACGAT-
GTTCCAGATTACGCTA-39 and 59-GATCTAGCGTAATCT-
GGAACATCGTATGGGTAG-39 was inserted into the
EcoRI–BglII sites of pCMV-FLAG-p7 and the resultant
plasmid was named pCMV-HA-p7. Next, the PCR prod-
uct obtained with oligonucleotides 59-TTGTGGTT-
GAGATCTGCGCCTATCACGGCCTATTC-39 and 59-
TTGTGGTTGAAGCTTTCAGGTGCTCTTGCCGCTG-
CCAG-39 (NS3-AS) for pCMV-DCore-NS3.1 and
oligonucleotides 59-ACTGGTTGAGATCTGGTCGGGA-
CAAGAA C-39 and NS3-AS for pCMV-DCore-NS3.2 as
primers was replaced with the BglII–HindII digests of
pCMV-HA-p7 (these resultant plasmids were named
pCMV-NS3.1 and pCMV-NS3.2, respectively). The third
insert was amplified using core-s and 59-ACAGAAT-
TCGGGTGACAGGAGCCATC-39 as primers and pCMV-
DCore151 (NLS mut) as the template, followed by in-
sertion into pCMV-NS3.1 and pCMV-NS3.2 to produce
pCMV-DCore-NS3.1 and pCMV-DCore-NS3.2, respec-
tively.
Cell culture
NIH3T3 and HepG2 cells were cultured in Dulbecco’s
modified Eagle’s medium (Nissui) with 10% fetal bovine
serum and L-glutamine at 37°C.
Transfection of cells
The DNA transfection experiment was performed us-
ing FuGENE 6 transfection reagent (Boehringer Mann-
heim) as described previously (Marusawa et al., 1999).
Reporter plasmid assay
Luciferase activity was measured by a luminometer
with a dual-luciferase reporter assay system kit (Pro-
mega) as recommended by the manufacturer. The re-
porter pNF-kB-Luc (Stratagene) vector containing the
NF-kB binding elements upstream of the minimum pro-
moter region driving the firefly luciferase reporter gene
was used. In this assay system, the Renilla luciferase
activity from the pRL-TK (Promega) vector containing the
herpes simplex virus thymidine kinase promoter up-
stream of the Renilla luciferase gene was also monitored
to normalize firefly luciferase activity.
Immunoblotting analysisThe preparation of cell lysate, sodium dodecyl sulfate
(SDS)–polyacrylamide gel electrophoresis, and immuno-blotting analysis were performed as described previ-
ously (Marusawa et al., 1999). The antibodies used in this
study were those against HCV core protein (515S; a
generous gift from Dr. Kohara, Tokyo Metropolitan Insti-
tute of Medical Science), NS4A protein (anti-NS4A), and
FLAG epitope (anti-FLAG M2, Sigma).
Immunofluorescence
The immunofluorescence analysis was performed as
described previously (Marusawa et al., 1999). The cells
were permeabilized with 0.05% Triton X-100. The primary
antibodies used in this experiment were 515S, anti-
NS4A, anti-FLAG, or anti-Grp78 (StressGen Biotechnolo-
gies Corp.). The secondary antibodies were Alexa 568
goat anti-mouse IgG (H 1 L) and Alexa 488 goat anti-
rabbit IgG (H 1 L) conjugates (Molecular Probes, Eu-
gene, OR). The nucleus was stained using 49, 6-dia-
midino-2-phenylindole (DAPI). In the experiment with dig-
itonin, we treated the cells with buffer containing 20 mM
HEPES–KOH (pH 7.3), 110 mM potassium acetate, 2 mM
magnesium acetate, 1 mM EGTA, 2 mM dithiothreitol,
and 40 mg/ml digitonin on ice for 5 min instead of with
0.05% Triton X-100.
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